BioSpace News Archive

Policy

NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System

NeuroOne Medical Technologies Corporation announced that it has responded to the Food and Drug Administration’s questions regarding the Company’s previous submission of a 510 for its OneRF™ Ablation System.

November 7, 2023
·
5 min read
Biotech Beach

Aligos Therapeutics to Present Multiple Posters at AASLD’s The Liver Meeting® 2023, Highlighting Progress for Its Clinical Stage Portfolio

Aligos Therapeutics, Inc. today announced that the company is presenting six posters at the American Association for the Study of Liver Diseases’ (AASLD) The Liver Meeting® 2023, taking place in Boston, Massachusetts, November 10 – 14, 2023.

November 7, 2023
·
4 min read
Biotech Beach

Poseida Therapeutics to Present at Two Upcoming Investor Conferences - November 7, 2023

Poseida Therapeutics, Inc. today announced that the Company will participate in the following upcoming investor conferences in November.

November 7, 2023
·
1 min read
Business

UroGen Pharma to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023

UroGen Pharma Ltd. today announced that it will report third quarter 2023 financial results on November 14, 2023, at 8:00 AM EDT, prior to the open of the market.

November 7, 2023
·
1 min read
Biotech Bay

Nutcracker Therapeutics Demonstrates Anti-tumor Responses of Two Preclinical mRNA Drug Candidates at 2023 SITC Annual Meeting

Nutcracker Therapeutics, Inc. today presented preclinical data for two of its therapeutic candidates: its latest therapeutic candidate, NTX-471, which targets CD47; and the company’s lead mRNA candidate targeting human papillomavirus (HPV)-driven tumors, NTX-250.

November 7, 2023
·
4 min read
Drug Development

Gate Neurosciences Announces Positive Topline Human EEG Biomarker Results Demonstrating Dose-Dependent Target Activation in Phase 1 Study of Apimostinel

Gate Neurosciences, a clinical-stage biotechnology company using precision medicine approaches to develop next-generation neuroscience therapies, today announced positive topline qEEG biomarker and safety results from its Phase 1 multiple ascending dose study of apimostinel in healthy volunteers.

November 7, 2023
·
4 min read
Biotech Bay

OrsoBio Announces $60M Series A Financing to Advance Metabolic Portfolio for the Treatment of Obesity and Associated Disorders

OrsoBio, Inc. today announced the successful completion of a $60 million Series A financing, bringing the total capital raised by the Company to $97 million.

November 7, 2023
·
5 min read
Genetown

Moderna Tops BioSpace’s Best Places to Work Ranking for Third Consecutive Year

Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked the number one large employer in BioSpace’s 2024 Best Places to Work report for the third consecutive year.

November 7, 2023
·
3 min read
Business

Resilience Appoints Bill Marth as President of Services

National Resilience, Inc. today announced that William S. Marth, RPh., MBA has been appointed to the newly created role of President of Services.

November 7, 2023
·
2 min read
Drug Development

Qualigen Therapeutics Announces First Patient Dosed in the Phase 1a Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors

Qualigen Therapeutics, Inc. announces today that the first patient in the Phase 1a clinical trial has been dosed with QN-302, a potential first-in-class, investigational G-Quadruplex (G4)-selective transcription inhibitor designed for the treatment of advanced or metastatic solid tumors.

November 7, 2023
·
6 min read